International Conference on Bioinformatics, Biomedicine, Biotechnology and Computational Biology (EUIC3BCB)

September 27-28, 2022 | Czech Republic

International Conference
The conference provides a platform for professionals involved in Bioinformatics, Biomedicine, Biotechnology and Computational Biology to exchange knowledge and gain an insight into the state of the art in the current technology,

Spotlight

A leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany. Showcased in eight oral presentations, 29 poster presentations and three symposia, these data underscore Shire's pursuit of treatment innovation rooted in safety, efficacy, and individualized care for hemophilia patients.


OTHER PAST CONFERENCES

Rare Drug Development Symposium

June 8-10, 2022 | USA

Rare disease research is rapidly evolving. But new models come with new challenges that must be addressed in order to bring treatments to those who need them as quickly and effectively as possible.

HealthOptimization, Longevity, Wellness

October 22-23, 2022 | USA

HealthOptimization, and Longevity. Listen to lectures, and ask your questions. Discover 30+ selected Health, Ecological products, and Digital Health technologies in Expo-zone.

Gold 2022

July 17-20, 2022 | Canada

Synthesis of nanoparticles and nanostructures, Gold-containing molecular and supramolecular complexes, High-purity gold synthesis and recycling, Catalysis, Electrochemistry, Plasmonics (fundamentals, engineering and systems), Electronics, optics and photonics, Biomedical applications of gold: in vivo applications and technologies, injectable nanoparticles and pharmacology and Biomedical applications of gold: sensors and devices

New Lipid and Lipoprotein Genes, Pathways and Therapies

June 5-10, 2022 | USA

The 2022 Lipoprotein Metabolism Gordon Research Conference (GRC) will be held at Waterville Valley Conference Center, NH on June 5- 10, 2022. This interdisciplinary meeting will include not only the latest findings on the role of lipoprotein metabolism in cardiovascular disease, as in previous GRCs on this topic, but also how the field of lipoprotein research forwarding towards identifying new genes, new targets and new therapies.

Spotlight

A leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany. Showcased in eight oral presentations, 29 poster presentations and three symposia, these data underscore Shire's pursuit of treatment innovation rooted in safety, efficacy, and individualized care for hemophilia patients.

resources